Form D · Biotechnology

Bioceptive, Inc.

New Orleans, LA · CIK 0001527900

Offering snapshot reported Jan 29, 2016 · SEC filing

Reported sold
$416K
Offering amount: $650K
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 18, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 29, 2016Initial$416,450No comparison16SEC filing
Dec 30, 2013Initial$1,250,000No comparison12SEC filing
Mar 1, 2013Amendment$1,063,610No comparison0SEC filing
Oct 24, 2012InitialYet to sellNo comparison0SEC filing
Mar 26, 2012Amendment$40,000$0vs Mar 26, 20122SEC filing
Mar 26, 2012Initial$40,000No comparison2SEC filing
Aug 15, 2011Initial$135,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-256301

Source: Form D, filed Jan 29, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tom Balderston Director
Benjamin Cappiello Director, Executive
Stewart Davis Director, Executive
John Hardman Director
Shuchi Khurana Executive
Orin Levy Director
Joseph Lovett Director
Joan Neuscheler Director
Amit Kumar Rathi Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
New Orleans Bioinnovation Center 1441 Canal Street, Suite 228
New Orleans, LA, 70112